The emerging role of fibrocytes in ocular disorders

被引：7
|
作者：
Zhang, Feng [1 ,2 ]
Liu, Ke [1 ,2 ]
Zhao, Han [1 ,2 ]
He, Yan [1 ,2 ]
机构：
[1] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 410011, Hunan, Peoples R China
[2] Hunan Clin Res Ctr Ophthalm Dis, Changsha 410011, Hunan, Peoples R China
来源：
STEM CELL RESEARCH & THERAPY | 2018年 / 9卷
基金：
中国国家自然科学基金;
关键词：
Fibrocytes; Mesenchymal progenitor cell; Fibrosis; Inflammation; Ocular disorders; THYROID-ASSOCIATED OPHTHALMOPATHY; PERIPHERAL-BLOOD FIBROCYTES; ATTENUATES BRONCHIOLITIS OBLITERANS; CIRCULATING FIBROCYTES; BONE-MARROW; PROLIFERATIVE VITREORETINOPATHY; MYOFIBROBLAST POPULATION; CHRONIC INFLAMMATION; EFFECTOR-CELLS; GROWTH-FACTOR;
D O I：
10.1186/s13287-018-0835-z
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The fibrocyte, which was first described in 1994, is a type of circulating mesenchymal progenitor cell in the peripheral blood. Fibrocytes play important roles in chronic inflammation, wound healing, tissue remodeling, and fibrosis. Emerging evidence indicates that fibrocytes are involved in a wide variety of ocular disorders associated with inflammation and fibrosis. In this review, we summarize recent advances regarding the general characteristic profile of fibrocytes, molecular mechanisms underlying the fibrocyte recruitment to target tissues, their differentiation into fibroblasts, and the potential role of fibrocytes in ocular disease. Given the critical role of fibrocytes in ocular disorders, fibrocytes may serve as a promising pharmaceutical target in the development of novel therapeutic strategies to treat ocular inflammation and fibrosis.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] The emerging role of fibrocytes in ocular disorders
    Feng Zhang
    Ke Liu
    Han Zhao
    Yan He
    Stem Cell Research & Therapy, 9
  • [2] The Emerging Role of Senescence in Ocular Disease
    Sreekumar, Parameswaran G.
    Hinton, David R.
    Kannan, Ram
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [3] The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders
    Keeley, Ellen C.
    Mehrad, Borna
    Strieter, Robert M.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 613 - 618
  • [4] The emerging role of nanozymes in ocular antioxidant therapy
    Xue, Bai
    Lu, Yu
    Wang, Shuyu
    Xiao, Qing
    Luo, Xinlan
    Wang, Yifei
    Yan, Xiyun
    Yang, Zhenglin
    Jiang, Bing
    NANO TODAY, 2024, 58
  • [5] Fibrocytes: emerging effector cells in chronic inflammation
    Peng, Hong
    Herzog, Erica L.
    CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 491 - 496
  • [6] Fibrocytes: emerging effector cells in chronic inflammation
    Ronald A. Reilkoff
    Richard Bucala
    Erica L. Herzog
    Nature Reviews Immunology, 2011, 11 : 427 - 435
  • [7] An Emerging Role for TARPs in Neuropsychiatric Disorders
    Gill, Martin B.
    Bredt, David S.
    NEUROPSYCHOPHARMACOLOGY, 2011, 36 (01) : 362 - 363
  • [8] The emerging role of complement in neuromuscular disorders
    Lee, John D.
    Woodruff, Trent M.
    SEMINARS IN IMMUNOPATHOLOGY, 2021, 43 (06) : 817 - 828
  • [9] The emerging role of integrins in neuropsychiatric disorders
    Carneiro, Ana M. D.
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (01) : 338 - 339
  • [10] Fibrocytes: emerging effector cells in chronic inflammation
    Reilkoff, Ronald A.
    Bucala, Richard
    Herzog, Erica L.
    NATURE REVIEWS IMMUNOLOGY, 2011, 11 (06) : 427 - 435
12345